Rhonda Lynette Hellums insider trades

Open-market stock purchases and sales by Rhonda Lynette Hellums, Chief Financial Officer at Silence Therapeutics plc, from SEC Form 4 filings since Feb 1, 2019.

Recent trades

DateStockTradeValue
Jan 2, 2026SLN Silence Therapeutics plcBought (not open market)—

Companies traded

  • SLN Silence Therapeutics plc: other filings, last Jan 2, 2026
  • PETX Aratana Therapeutics, Inc: other filings, last Jul 18, 2019

Get free alerts when Rhonda Lynette Hellums files a new trade →